2m 2m 2m 2m 2m 2m 2m
ISPECIMEN (ISPC)
NASDAQ
$2.99-$0.009 (-0.30%)
Price as of Jun 03, 2026 7:48 PM EDT- $4.5MMarket Cap
- -93.98%1-Year Change
- Diagnostics & ResearchIndustry
ISPECIMEN (ISPC)
$2.99-$0.009 (-0.30%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.9M -78.81% | 9.1M -8.29% | 9.9M -4.56% | 10.4M -6.58% | |
Cost of Revenue | 1.9M -64.08% | 5.3M +10.01% | 4.8M +1.33% | 4.8M -9.37% | |
Gross Profit | 24,110 -99.37% | 3.8M -25.56% | 5.1M -9.52% | 5.6M -4.09% | |
Sales and Marketing Expense | 2.3M -53.58% | 4.9M +25.01% | 4.0M +14.82% | 3.4M +42.21% | |
Research and Development Expense | -2.2M +44.63% | -1.5M -7.75% | -1.6M +9.86% | -1.5M +398.98% | |
Depreciation and Amortization Expense | 191,555 0.00% | 191,555 +286.82% | 49,520 -95.81% | 1.2M +23.38% | |
Total Operating Expenses | 10.9M -50.47% | 22.0M +4.37% | 21.1M +2.47% | 20.6M +20.68% | |
Operating Profit | -9.0M -29.46% | -12.7M +13.96% | -11.2M +9.65% | -10.2M +71.91% | |
Interest Income | 3,748 -91.51% | 44,133 -87.01% | 339,750 +100.63% | 169,345 +1,385.87% | |
Interest Expense | N/A N/A | N/A N/A | -16,001 -93.30% | -238,963 -88.64% | |
Interest Income and Expense and Net | 3,748 -91.51% | 44,133 -86.37% | 323,749 +565.04% | -69,618 -96.67% | |
Total Nonoperating Income and Expense | -1.5M -755.67% | 230,240 +229.57% | 69,861 +216.75% | -59,840 +34.38% | |
Income before Taxes | -9.0M -29.46% | -12.7M +13.96% | -11.2M +9.65% | -10.2M +71.91% | |
Income Taxes | N/A N/A | N/A N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -10.5M -16.09% | -12.5M +12.60% | -11.1M +8.33% | -10.2M +14.33% | |
Net Income from Continuing Operations Applicable to Common | -10.5M -16.09% | -12.5M +12.60% | -11.1M +8.33% | -10.2M +14.33% | |
Basic EPS and Net Income | -2.28 -87.03% | -17.58 +1,329.27% | -1.23 +6.03% | -1.16 -44.50% | |
Diluted EPS and Net Income | -2.28 -87.03% | -17.58 +1,329.27% | -1.23 +6.03% | -1.16 -44.50% | |
Basic Weighted Average Shares | 4.6M +547.46% | 710,852 -92.14% | 9.0M +2.23% | 8.8M +106.28% | |
Diluted Weighted Average Shares | 4.6M +547.46% | 710,852 -92.14% | 9.0M +2.23% | 8.8M +106.28% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 6.9M +266.31% | 1.9M -19.85% | 2.3M -84.69% | 15.3M -44.81% | |
Short-Term Investments | N/A N/A | N/A N/A | 2.7M N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 6.9M +266.31% | 1.9M -62.47% | 5.0M -67.30% | 15.3M -44.81% | |
Total Current Assets | 7.0M +93.83% | 3.6M -56.45% | 8.2M -58.13% | 19.7M -40.28% | |
Accumulated Depreciation | 410,539 +20.02% | 342,065 -23.08% | 444,731 +35.93% | 327,188 +6.47% | |
Property and Plant and Equipment and Net | 25,543 -72.70% | 93,563 -26.78% | 127,787 -43.42% | 225,852 +588.97% | |
Total Long-Term Assets | 25,543 -72.70% | 93,563 -26.78% | 127,787 -43.42% | 225,852 +588.97% | |
Total Assets | 9.5M +1.94% | 9.4M -40.89% | 15.8M -35.74% | 24.6M -31.08% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | 1.0M N/A | N/A N/A | 0 -100.00% | |
Total Current Liabilities | 6.2M +7.99% | 5.8M -4.60% | 6.0M +41.29% | 4.3M +70.87% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | 3.4M -4.97% | |
Total Long-Term Liabilities | 211,873 -21.18% | 268,798 +822.75% | 29,130 +6.33% | 27,396 -99.20% | |
Total Liabilities | 6.4M +6.69% | 6.0M -0.64% | 6.1M +41.07% | 4.3M -27.32% | |
Retained Earnings | -82.4M +14.59% | -71.9M +21.05% | -59.4M +23.00% | -48.3M +26.95% | |
Total Stockholders Equity | 3.1M -6.73% | 3.3M -66.01% | 9.7M -52.04% | 20.3M -31.83% | |
Total Shares Outstanding | 8.5M +399.65% | 1.7M -81.32% | 9.1M +1.77% | 8.9M +2.20% | |
Cash Flow | |||||
Cash from Operating Activities | -4.2M -48.68% | -8.3M +42.29% | -5.8M -0.17% | -5.8M -45.47% | |
Capital Expenditures | 454 -98.56% | 31,546 +61.96% | 19,478 -90.96% | 215,504 +8,351.14% | |
Cash from Investing Activities | -1.0M -150.54% | 2.0M +127.39% | -7.2M +126.51% | -3.2M +207.46% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 10.2M +76.04% | 5.8M +8,108.47% | 70,889 +102.07% | -3.4M -108.83% | |
Financials Ratio | |||||
Gross Margin | 1.25% -97.01% | 41.76% -18.83% | 51.45% -5.20% | 54.27% N/A | |
Operating Margin | -465.42% +232.94% | -139.79% +24.26% | -112.50% +14.89% | -97.92% N/A | |
Return on Assets | -111.09% +11.86% | -99.31% +80.90% | -54.90% +61.64% | -33.96% N/A | |
Return on Equity | -327.77% +71.16% | -191.51% +159.24% | -73.87% +80.61% | -40.90% N/A | |
Revenue Growth | -78.81% +850.49% | -8.29% +81.93% | -4.56% -30.76% | -6.58% N/A | |
Current Ratio | 1.12 +79.50% | 0.62 -54.35% | 1.36 -70.37% | 4.60 N/A | |
Cash Ratio | 1.10 +239.23% | 0.33 -16.00% | 0.39 -89.16% | 3.58 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 0.17 N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.14 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow